Timmerman Report

The Long Run with Luke Timmerman

Science EN ↓ 202 episodes

"The Long Run"Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join ho...

Author

Timmerman Report

Category

Science

Podcast website

soundcloud.com

Latest episode

Jun 30, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity 01.12.2021

Jeff Bluestone, CEO of Sonoma Biotherapeutics, on engineered T-reg cell therapies for autoimmunity.

Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer 23.11.2021

Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.

Ep102: David Baltimore Reflects on a Life in Science 08.11.2021

David Baltimore, professor emeritus at Caltech, reflects on a life in science.

Ep101: Tony Kulesa on Fostering Founder-Led Biotechs 26.10.2021

Tony Kulesa of Petri.bio on fostering founder-led biotech companies

Ep100: Christian Henry on Long Read DNA Sequencing 13.10.2021

Christian Henry, CEO of PacBio, on long read DNA sequencing applications.

Ep99: Keolu Fox on Genome Sequencing of Indigenous Populations 27.09.2021

Keolu Fox, assistant professor at UC San Diego, on genome sequencing of indigenous populations.

Ep98: Mara Aspinall on Diagnostics and COVID-19 13.09.2021

Mara Aspinall of Arizona State University on diagnostics and COVID-19.

Ep97: John Evans on Base Edited Therapeutics 07.09.2021

John Evans, CEO of Beam Therapeutics, on base editing technology for therapeutics.

Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids 09.08.2021

Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids

Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader 26.07.2021

Sue Desmond-Hellmann on becoming a physician-scientist and biotech industry leader.

Ep94: Jenny Rooke on Investing in Biotech Tools 19.07.2021

Jenny Rooke of Genoa Ventures on investing in biology & technology.

Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists 14.06.2021

Ep93: Jay Bradner of Novartis & Andy Plump of Takeda on Mentoring Young Scientists

Ep92: Brad Gray on Spatial Biology 01.06.2021

NanoString Technologies CEO Brad Gray on tools for spatial biology.

Ep91: Daphne Zohar on Biotech Entrepreneurship 03.05.2021

Daphne Zohar, CEO of Puretech Health, on starting biotech companies.

Ep90: James Sabry on Partnering Amid Scientific Abundance 19.04.2021

James Sabry, global head of pharma partnering for Roche, on partnering in a time of scientific abundance.

Ep89: Emily Leproust on DNA Synthesis at Scale 29.03.2021

Emily Leproust, co-founder and CEO of Twist Bioscience, on DNA Synthesis at Scale

Ep88: Amy DuRoss on software and logistics for cell and gene therapy 15.03.2021

Amy DuRoss, CEO of Vineti, on software and logistics for cell and gene therapy.

Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing 01.03.2021

Bob Nelsen of ARCH Venture Partners on long-term trends in biotech investing.

Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease 09.02.2021

Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.

Ep85: Luhan Yang on CRISPR Editing for Organ Transplants 20.01.2021

Luhan Yang, CEO of Qihan Bio, on CRISPR editing for organ transplants.

Ep84: Steve Paul on Treatments for Mental Health 22.12.2020

Steve Paul, CEO of Karuna Therapeutics, on neuropsychiatric drug development.

Ep83: David Lee on Impact in Pharmaceuticals 14.12.2020

David Lee, CEO of Servier Pharma, on a nonprofit model.

Ep82: Andrew Farnum on Medicines From Unusual Traits 23.11.2020

Andrew Farnum, CEO of Variant Bio, on drug discovery based on rare genetic traits.

Ep81: Simba Gill on Microbiome Therapies 12.11.2020

Simba Gill, CEO of Evelo Biosciences, on microbiome therapies.

Ep80: Peter Kolchinsky on Pharma's Soul 28.10.2020

Peter Kolchinsky of RA Capital on making drugs affordable, and keeping incentives for drug discovery.

Listen to the The Long Run with Luke Timmerman podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.